Technology Holding, LLC — Department of Defense SBIR Phase I: DHA202-003
Technology Holding, LLC — SBIR Phase I award from Department of Defense.
- Amount
- $249,563
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- SBIR · Phase I
- Topic
- DHA202-003
- Solicitation
- 20.2
- NAICS
- —
- Place of performance
- UT
- Period
- 2021-02-10 → 2021-09-09
Description
Antibiotic resistant infections are a principal concern for the Department of Defense and society at large due to the current lack of available treatments. Monoclonal antibodies represent a promising drug class that could be applied to antibiotic resistant infections to harness a patients own immune system to effectively combat the invading threat. In this program we present an optimized workflow to yield high affinity monoclonal antibody candidates against surface antigens from common infectious disease which is increasingly antibiotic resistant.